The outlook of companies tied to Viagra's legacy presents a complex investment landscape. While the initial boom generated substantial profits , generic alternatives have significantly impacted sales . Investing in associated pharmaceutical businesses now requires a thorough assessment of proprietary safeguards, evolving medical changes, and the pr